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Most farmers use intramammary antibiotics to treat clinical mastitis in dairy cows. During the 
acute phase of mastitis, the swelling of the intramammary tissue causes occluded milk ducts. 
This may prevent distribution of the infused antibiotic and consequently result in failure of the 
intramammary therapy. A combination of intramuscular and intramammary therapy may 
overcome these problems. Therefore this combination therapy is a recognised and accepted 
practice among many veterinarians. Combination therapy has resulted in better bacteriological 
cure rates of mastitis (Ziv, 1980; Owens et al, 1988; Owens et al., 1990). But combination 
therapy is considered off label use and problems with residues in milk may occur, as the 
prescribed withdrawal period is not reliable anymore. The prescribed withdrawal period of an 
antibiotic preparation is based on the excretion time of antibiotics in milk after treatment of 
healthy cows according to the label. Oliver et al. (1990) and Pedersoli et al. (1995) showed that 
the combination of intramammary and intramuscular therapy was associated with longer 
excretion periods of antibiotics in milk compared to single intramammary therapy. However, 
these studies used healthy cows instead of cows with mastitis. To gain better insight in the 
possible risks of exceeding the prescribed withdrawal period when using combination therapy 
under practical circumstances, it is necessary to use cows with mastitis instead of healthy cows. 
The objective of our study was to investigate the effect of combining intramammary and 
intramuscular mastitis therapy on the excretion time of antibiotics in milk. 
Materials and Methods 
The study was carried out on five experimental farms. Three comparisons of treatments were 
used in the study namely, A vs. A&C or B vs. B&D or A vs. A&E. Within a farm, cows that had 
naturally occurring mastitis were treated alternately with either a single intramammary therapy 
(A or B) or a combination of intramammary (A or B) and intramuscular (C, D or E) therapy. 
Two consecutive treated cows were called pairs. Cows that had received an antibiotic treatment 
over the last 14 days or cows that needed veterinary assistance were not included in the study. In 
total, every treatment was applied to eight cows, with a minimum of two cows per farm. If eight 
cows per treatment were reached, farms were appointed to treat cows with another treatment. 
The antibiotic preparations that were used are presented in Table 1. 
The farmers recorded appearance of the milk, udder and cow during 10 days after the start of the 
treatment. Sampling of composite milk samples started 4 milkings before the end of the 
withdrawal period (of the intramammary product) till 6 milkings after the end of the withdrawal 
period. It was not an objective of the present study to investigate treatment effects on milk yield 
and clinical cure. However, these parameters may affect the excretion time of antibiotics and for 
that reason these parameters were also analysed. 
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Table 1. Preparation code, route of administration, antibiotic preparation, administered 
amount and the withdrawal periods of the five preparations (WP in milkings). 
Code Route Antibiotic preparation Administered amount at each farm WP 
"Ä i.m.m.1 amoxicillin (200 mg) 1 Vi days 2 dd3 at farm 2 4 
clavulanic acid (50 mg) 2lA days 2 dd at farm 3, 4 & 5 
B i.m.m. dihydrostreptomycin (100 mg) 3 days ldd at farm 1 & 4 10 
nafcillin (100 mg) 3 days 2 dd at farm 5 
penicillin G (300.000 I.E.) 
~C Tin? amoxicillin (140 mg/ml) 1 day ldd at farm 2 2 
clavulanic acid (35 mg/ml) 2 days 1 dd at farm 3 and 5 
1 ml/ 20kg bw/day 
D i.m. penicillin G (15 mg/kg bw/day) 1 Vi days 2 dd at farm 1 & 4 6 
2 days 2 dd at farm 5 
E i.m. sulfadoxin (200 mg/ml) 1 lA days 2 dd at farm 2 6 
trimethoprim (40 mg/ml) 2'/2 days 2 dd at farm 4 
1 ml/16 kg bw/day 
1
 i.m.m. = intramammary;2 i.m. = intramuscular;3 = daily dose 
Milk samples were analysed for presence of dihydrostreptomycin (Berendsen, 2000), 
amoxicillin, nafcillin and penicillin G (Zuidema, 2000) by means of high performance liquid 
chromatography using tandem mass spectrometry for identification and quantification. 
Statistical Analysis 
The excretion time (EXCR) was defined as the number of milkings needed for the antibiotic 
residue concentration to get below the MRL after start of milk sampling. It must be noticed that 
the definition of excretion time used in the present study is not the same as the excretion time of 
antibiotics on which the withdrawal period is based. Milk yield (MILK) was defined as the milk 
yield at the 10th day after start of treatment. Clinical cure (NMCure) was defined as the milking 
after onset of treatment at which the milk, udder and cow appeared normal again. The effect of 
treatment on EXCR and NMCure was examined using the generalised linear mixed model 
analysis (GLMM) with a logarithmic link function and Poisson distribution. MILK was analysed 
with the residual maximum likelihood method (REML) (Genstat 5 Release 4.1, 1998). Although 
the study was set up to treat cows randomly, it appeared that cows were not exactly equally 
distributed over parities (PAR) and stage of lactation (DIM). Therefore these potential 
confounders were included in the statistical model. The model used for all response variables 
was: 
EXCRijkimno, NMCureijkimno or MILKijkimno =M + herdj + herd(pair of cows)ij + DIMk + PAR) + 
TREATm + COMBn + (TREAT* COMB)mn + eUklmno 
Where 
Response variable: EXCR = excretion time of antibiotics after start of milk sampling; NMCure = 
milking at which udder, milk and cow appeared normal again; MILK = milk yield at 10th day 
after onset of treatment; // = overall mean. Random effects: herdj = herd i representing 
differences between herds; herd(pair of eows)jj = pair of cows j within herd i representing 
differences between pairs within herd. Fixed effects: DIMk = k days in milk; PARt = parity; 
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TREATm = treatment comparison group (m = A&C, A&E, B&D); COMBn = additional 
intramuscular administration of C, D or E (n = yes, no); ejjkimno = residual random error. 
Results 
A total of 64 cows were treated with either an intramammary therapy or with a combination of 
intramammary and intramuscular therapy. Of the 64 cows, 16 were withdrawn from the study 
because the prescribed treatment appeared to be unsuccessful. There was no difference in 
withdrawal between single and combined treatments. The other 48 cows were treated as 
described in Table 2. Because of differences in mastitis incidence between farms, the total 
number of treated cows varied. Mean parity was 3 and the cows were on average 132 days in 
milk. Mean daily milk yield during the first ten days after onset of treatment was 25.8 kg/day. 
Table 2. The number of 
Therapy 
A 
A+C 
A 
A+E 
B 
B+D 
Total 
Farm 1 
2 
2 
4 
cows perl 
Farm 2 
3 
3 
6 
6 
18 
treatment per 
Farm 3 
2 
2 
4 
farm. 
Farm 4 
2 
2 
4 
4 
12 
Farm 5 
3 
3 
2 
2 
10 
Number of cows 
8 
8 
8 
8 
8 
8 
48 
The prescribed withdrawal periods were exceeded 4 times after single intramammary therapy 
and 4 times after combination therapy. 
The three treatment comparison groups appeared to have a significant effect on EXCR (P<0.05). 
However, the additional intramuscular administration in the combination therapy did not 
significantly increase EXCR (P=0.2), although the estimated mean EXCR was higher for 
combination A&C and B&D than for single A and B respectively. DIM and parity did not 
significantly affect EXCR. The back transformed estimated means for EXCR are presented in 
Table 3. 
Table 3. Estimated 
Treatment 
A 
A&C 
B 
B&D 
A 
A&E 
mean EXCR and mean NMCure for 
Estimated EXCR 
2.35 
3.42 
0.30 
0.83 
2.96 
2.65 
every treatment (in milkings). 
Mean NMCure 
5.3 
5.6 
6.0 
6.0 
4.5 
3.8 
NMCure was not significantly influenced by any of the parameters in the model. Therefore only 
the mean NMCure is presented in Table 3. 
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DIM and parity had a significant positive effect on MILK (PO.05). The combination therapy 
showed a tendency (P=0.08) towards a higher estimated milk yield (29.0 kg/day) compared to 
the single therapy (26.5 kg/milking). 
Discussion and Conclusion 
This study showed no significant differences in excretion time of residues in milk between single 
intramammary therapy and combination therapy. This result is not in accordance with studies of 
Oliver et al. (1990) and Pedersoli et al. (1995). However, Pedersoli et al. (1995) used 
gentamycine in combination therapy for five days. The mean excretion time of combination 
A&C (both amoxycillin) was one milking longer than the intramammary treatment A (not 
significant). If A and A&C had been administered for a longer period, the difference in excretion 
time might have been more clear. 
The prescribed withdrawal period was exceeded 8 times. In 4 cases it was after combination 
therapy and the other 4 cases were after intramammary therapy. In three of these 4 cases, the 
intramammary antibiotic was applied exactly according to the label. The fact that exceeding of 
the withdrawal period is associated with off label use of antibiotics seems logically, since the 
withdrawal period is not reliable anymore. However, the withdrawal period was also exceeded in 
cows that were treated exactly according to the label. Consequently, antibiotic excretion in milk 
from cows with mastitis may differ from the excretion of antibiotics in milk from healthy cows, 
on which the withdrawal period is based. 
Studies of Ziv (1980) and Owens et al. (1988) reported a positive effect of combination therapy 
on bacteriological cure rate. However, they did not investigate milk production. Milk production 
data also give important information about the recovery of the mammary gland function. In the 
present study it was found that cows treated with the combination therapy tended to produce 
more milk after treatment than cows treated with the single therapy. There was no information 
about the milk production of cows before the onset of treatment, but corrections were made for 
DIM and parity. The slightly higher milk production in cows treated with the combination 
therapy might indicate that the secretory activity is increased during combination therapy, as 
suggested by Owens et al. (1990). Although it was found that milk production was higher, there 
were no differences in clinical cure between the single and combination therapy. In order to 
define differences in clinical cure between treatments, a clinical trial should be conducted. The 
present study was not meant as a clinical trial and did not meet the requirements for a clinical 
trial (Schukken and Deluyker, 1995). 
Although the differences in excretion time between the single and combined treatments were not 
significant, there seemed to be a difference between A and A&C. Differences in excretion time 
might have been more pronounced if milk production was not influenced by treatment. The 
results give some interesting information but further study is necessary to confirm these initial 
findings. 
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